top of page

WELCOME TO OUR VIRTUAL POSTER HALL

(Please click on each button to view and download the posters)

LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects With NAFLD and T2D

Baum_GHAPP21 1125 Insulin Resistance poster_KL05_FINAL_UPLOAD.jpg
Cave GHAPP 2021 QI Project Identifies 660 People with HCV 36x48.jpg

A Single-Center Continuous Quality Improvement Program Identifies
660 Hepatitis C Infected Persons in
One Year

HCC Innovations

CLDF-20-14 HCC Innovations Abstract Poster_GHAPP_48x36_v2.jpg
Dellon et al. EoE Phase 3 Part A primary_GHAPP 2021_poster-Sep 3.jpg

Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Part A of a Randomized, Placebo-Controlled, Three-Part, Phase 3 Study

Dupilumab Reduces Symptom Burden and Improves Health-Related Quality of Life in Patients With Eosinophilic Esophagitis: Results From Part A of a Randomized, Placebo-Controlled, Three-Part, Phase 3 Study

Dellon_EoE P3 PA EoE-IQ EoE-SQ PGIC_GHAPP 2021_poster_Sep 3.jpg
Dubinsky_Eli Lilly_GHAPP 2021_AMAC urgency (12 and 52W)_Poster.jpg

Mirikizumab Treatment Improves
Bowel Movement Urgency in Patients
with Moderately to Severely Active Ulcerative Colitis

Absence of Bowel Urgency is Associated with Significantly Improved Inflammatory Bowel Disease Related Quality of Life in a Phase 2 Trial of Mirikizumabin Patients with Ulcerative Colitis

Dubinsky_Eli Lilly_GHAPP 2021_AMAC urgency vs IBDQ_Poster.jpg
GERD and Probiotics poster.jpg

Efficacy of Probiotic Use and Gastroesophageal Reflux Disease Symptom Management

Clinical Update on the Management of Patients
with Cirrhosis

GHAPP-21-04 Abstract Poster_GHAPP_48x36_v2 (1).jpg
GHAPP2021_LACY_FINAL.jpg

Disease burden and care-seeking behavior for IBS-C patients in the United States in the era of COVID-19

Safety, Tolerability, and Biological Activity of AXA1125 and AXA1957 in a Prospective 16-Week Randomized, Placebo-Controlled Study in Subjects With NAFLD With and Without Type 2 Diabetes

Harrison_GHAPP21 1125 Primary Poster_KL04_FINAL_UPLOAD.jpg
Lim_HCC Oral Week 240 GHAPP 2021 v4.jpg

Impact of Treatment With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate on Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B

Rapid Onset of Time to First Spontaneous Bowel Movement (SBM) and Predictable Efficacy of Naloxegol: Pooled Analysis of Two Global Randomized Controlled Trials

Movantik_GHAPP_2021_FINAL.jpg
Regueiro_Eli Lilly_GHAPP 2021_AMAG 12 and 52W Fatigue_Poster.jpg

Mirikizumab Therapy is Associated with Improved Fatigue in Patients with Moderately to Severely Active Crohn’s Disease

Efficacy and Safety of Mirikizumab After 52-Weeks Maintenance Treatment in Patients with
Moderate-to-Severe Crohn’s Disease

Sands_Eli Lilly_GHAPP 2021_AMAG EffSaf - (52W)_Poster.jpg
Sands_Eli Lilly_GHAPP 2021_AMAG Prim EffSaf 12W-LB_Poster.jpg

Efficacy and Safety of Mirikizumab (LY3074828) After 12 Weeks Induction Treatment in a Phase 2 Study of Patients with Crohn’s Disease

Pitfalls of Physician-Directed Treatment of Helicobacter pylori Infection: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data

Talicia_GHAPP_2021_Final.jpg
Thelen, Kendall.jpg

Implementing a Hepatitis C Compliance Program

bottom of page